Provided by Tiger Trade Technology Pte. Ltd.

Contineum Therapeutics, INC.

17.19
+1.177.30%
Post-market: 17.190.00000.00%19:30 EDT
Volume:353.91K
Turnover:6.02M
Market Cap:646.71M
PE:-9.99
High:17.35
Open:16.18
Low:15.88
Close:16.02
52wk High:17.35
52wk Low:8.60
Shares:37.62M
Float Shares:27.82M
Volume Ratio:0.42
T/O Rate:1.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7201
EPS(LYR):-2.1700
ROE:-28.01%
ROA:-19.15%
PB:2.70
PE(LYR):-7.92

Loading ...

Apr 30, 2026

Major Issues Report

Form 8-K - Current report
Apr 17, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 05, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 05, 2026

Major Issues Report

Form 8-K - Current report
Feb 12, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 11, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 26, 2026

Major Issues Report

Form 8-K - Current report
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 23, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2025

Major Issues Report

Form 8-K - Current report
Dec 11, 2025

Major Issues Report

Form 8-K - Current report
Nov 20, 2025

Major Issues Report

Form 8-K - Current report
Oct 31, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 30, 2025

Major Issues Report

Form 8-K - Current report
Sep 18, 2025

Major Issues Report

Form 8-K - Current report
Aug 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]